CIK 0001813814 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Definium Therapeutics, Inc.
Sign in to watch- Ticker
- DFTX
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- 212-220-6633
- Business address
- ONE WORLD TRADE CENTER, SUITE 8500, NEW YORK, NY, 10007
- Former names
- Mind Medicine (MindMed) Inc.
- 144 Insider Sale of Securities
- 4 Open-market buy Director bought 3,500 shares at $5.98 ($20,930)
- 4 Shares withheld for taxes Executive President gave up 32,595 shares (to pay taxes)
- 4 Open-market buy Chief Executive Officer bought 1,000 shares at an average $6.22 ($6,215)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Material agreement · Results of operations · Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Other events
- S-3ASR Offering Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Planned sale Chief Medical Officer sold 6,925 shares at $7.22 ($49,999)
- 4 Planned sale Chief Legal Officer sold 17,854 shares at $7.22 ($128,906)
- 4 Planned sale Chief Executive Officer sold 15,659 shares at $7.22 ($113,058)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Other events
- 4 Derivatives Options or other derivatives
Page 10 of 26 · 506 filings